PI Industries Limited — Others, 14-08-2025: Shareholders meeting

PI Industries held its 78th Annual General Meeting, reviewing a resilient FY2025. Standalone revenue grew 5.96% to ₹7,571.2 Cr, with net profit up 7.84% to ₹1,866.5 Cr. Consolidated revenue rose 4.07% to ₹7,977.8 Cr. The company confirmed an interim dividend of ₹6.00 per share and proposed a final dividend of ₹10.00 per share. Key agenda items included adopting financial statements and re-appointing directors. Strategically, PI launched 13 new products, commercialized 7 new molecules, and filed 44 patents. Significant capex of ~₹130 Cr was invested in Pharma. The acquisition of Plant Health Care PLC strengthens its biologicals segment, aligning with the company's diversification into a broader life-sciences powerhouse, including CRDMO and electronic chemicals.